Hannah Raji,
Oswitha Dsouza,
Freeda Princy Dsouza,
- Student Department of Biochemistry, St Aloysius College, Mangaluru Karnataka India
- Student Department of Biochemistry, St Aloysius College, Mangaluru Karnataka India
- Student Department of Biochemistry, St Aloysius College, Mangaluru Karnataka India
Abstract
Introduction: The Hippo pathway plays a pivotal role in renal disease, with Yes-associated protein (YAP) exhibiting promise for combined treatments. The crucial evaluation of YAP-targeted drug safety and efficacy through preclinical studies is imperative. Additionally, α-SMA and SMAD3 emerge as potential therapeutic targets in renal fibrosis, driving ongoing research toward innovative interventions. Materials and Methods: In the systematic identification of therapeutic secondary metabolites, Anthocyanin derivatives were methodically retrieved from the IMPPAT database. Ten distinct compounds underwent curation, and their molecular structures were systematically acquired. Molecular targets, including YAP, TGF-β1, SMAD3, and α-SMA, were precisely identified. Three- dimensional structures were meticulously sourced from the PDB and underwent purification. The process of molecular docking, facilitated by PyRx, coupled with a comprehensive in silico evaluation of ADMET properties, enhances our understanding of the therapeutic potential of Anthocyanin derivatives, with the ultimate goal of streamlining drug discovery processes. Results: The ligands sourced from the IMPPAT database underwent a stringent molecular docking process to validate structural integrity. The confirmation of protein suitability for docking was achieved through hydropathy analysis and Z-score plots. Notably, Alpha-boswellic acid demonstrated superior binding affinity, exhibiting significant promise for therapeutic applications. Additionally, the systematic analysis of Anthocyanin phytocompounds for ADMET properties revealed distinct bioactivity, providing valuable guidance for potential drug development. Conclusion: To summarize, the exploration of intricate interactions between the Hippo pathway and renal diseases presents novel prospects for targeted therapeutic interventions. Whether through YAP-targeted drugs, the modulation of α-SMA and SMAD3, or the incorporation of flavonoids, the scientific insights not only enhance our comprehension of fundamental molecular mechanisms governing renal health but also hold the promise of substantial advancements in the field of renal disease treatments.
Keywords: Yes-Associated Protein, Transforming growth factor beta 1-β1, Suppressor of Mothers against Decapentaplegic 3, α- smooth muscle actin, Hippo- Transcriptional co-activator with PDZ- binding motif, Anti-inflammatory
[This article belongs to International Journal of Genetic Modifications and Recombinations(ijgmr)]
Browse Figures
References
- Luyckx VA, Tonelli M, Stanifer JW. The global burden of kidney disease and the sustainable development goals. Bulletin of the World Health Organization. 2018 Jun 6;96(6):414.
- Tsai, H.-J., Wu, P.-Y., Huang, J.-C., & Chen, S.-C. (2021). Environmental pollution and chronic kidney disease. International Journal of Medical Sciences, 18(5), 1121–1129. https://doi.org/10.7150/ijms.51594
- Luyckx VA, Tuttle KR, Garcia-Garcia G, Gharbi MB, Heerspink HJ, Johnson DW, Liu ZH, Massy ZA, Moe O, Nelson RG, Sola L. Reducing major risk factors for chronic kidney disease. Kidney international supplements. 2017 Oct 1;7(2):71-87.
- Anorga S, Overstreet JM, Falke LL, Tang J, Goldschmeding RG, Higgins PJ, Samarakoon R. Deregulation of Hippo–TAZ pathway during renal injury confers a fibrotic maladaptive phenotype. The FASEB Journal. 2018 May;32(5):2644.
- Sun Y, Jin D, Zhang Z, Xue J, Zhang Y, Kang X, Lian F. The critical role of the Hippo signaling pathway in kidney diseases. Frontiers in Pharmacology. 2022 Nov 22;13:988175.
- Zhao W, Wang X, Sun KH, Zhou L. α-smooth muscle actin is not a marker of fibrogenic cell activity in skeletal muscle fibrosis. PloS one. 2018 Jan 10;13(1):e0191031.
- Lan HY. Diverse roles of TGF-β/Smads in renal fibrosis and inflammation. International journal of biological sciences. 2011;7(7):1056.
- Ina K, Kitamura H, Tatsukawa S, Fujikura Y. Significance of α-SMA in myofibroblasts emerging in renal tubulointerstitial fibrosis. Histology and histopathology, Vol. 26, nº 7 (2011). 2011.
- Alappat B, Alappat J. Anthocyanin pigments: Beyond aesthetics. Molecules. 2020 Nov 24;25(23):5500.
- Ma Z, Du B, Li J, Yang Y, Zhu F. An insight into anti-inflammatory activities and inflammation related diseases of anthocyanins: A review of both in vivo and in vitro investigations. International Journal of Molecular Sciences. 2021 Oct 14;22(20):11076.
- Takshak S, Agrawal SÁ. Secondary metabolites and phenylpropanoid pathway enzymes as influenced under supplemental ultraviolet-B radiation in Withania somnifera Dunal, an indigenous medicinal plant. Journal of Photochemistry and Photobiology B: Biology. 2014 Nov 1;140:332-43.
- Zhao W, Wang X, Sun KH, Zhou L. α-smooth muscle actin is not a marker of fibrogenic cell activity in skeletal muscle fibrosis. PloS one. 2018 Jan 10;13(1):e0191031.
- Zhang Q, Wang L, Wang S, Cheng H, Xu L, Pei G, Wang Y, Fu C, Jiang Y, He C, Wei Q. Signaling pathways and targeted therapy for myocardial infarction. Signal transduction and targeted therapy. 2022 Mar 10;7(1):78.
- Park SW, Lee BH, Song SH, Kim MK. Revisiting the Ramachandran plot based on statistical analysis of static and dynamic characteristics of protein structures. Journal of Structural Biology. 2023 Mar 1;215(1):107939.
- Meng XY, Zhang HX, Mezei M, Cui M. Molecular docking: a powerful approach for structure-based drug discovery. Current computer-aided drug design. 2011 Jun 1;7(2):146-57.
- Dallakyan S, Olson AJ. Small-molecule library screening by docking with PyRx. Chemical biology: methods and protocols. 2015:243-50.
- Adelusi TI, Oyedele AQ, Boyenle ID, Ogunlana AT, Adeyemi RO, Ukachi CD, Idris MO, Olaoba OT, Adedotun IO, Kolawole OE, Xiaoxing Y. Molecular modeling in drug discovery. Informatics in Medicine Unlocked. 2022 Jan 1;29:100880.
- Khoo HE, Azlan A, Tang ST, Lim SM. Anthocyanidins and anthocyanins: Colored pigments as food, pharmaceutical ingredients, and the potential health benefits. Food & nutrition research. 2017 Aug 13.
- Agu PC, Afiukwa CA, Orji OU, Ezeh EM, Ofoke IH, Ogbu CO, Ugwuja EI, Aja PM. Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management. Scientific Reports. 2023 Aug 17;13(1):13398.
- Hollingsworth SA, Karplus PA. A fresh look at the Ramachandran plot and the occurrence of standard structures in proteins.
- Michel M, Visnes T, Homan EJ, Seashore-Ludlow B, Hedenström M, Wiita E, Vallin K, Paulin CB, Zhang J, Wallner O, Scobie M. Computational and experimental druggability assessment of human DNA glycosylases. ACS omega. 2019 Jul 5;4(7):11642-56.
- Wiederstein M, Sippl MJ. ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic acids research. 2007 Jul 1;35(suppl_2):W407-10.
- Corbeil CR, Englebienne P, Moitessier N. Docking ligands into flexible and solvated macromolecules. 1. Development and validation of FITTED 1.0. Journal of chemical information and modeling. 2007 Mar 26;47(2):435-49.
- Ayvaz H, Cabaroglu T, Akyildiz A, Pala CU, Temizkan R, Ağçam E, Ayvaz Z, Durazzo A, Lucarini M, Direito R, Diaconeasa Z. Anthocyanins: Metabolic digestion, bioavailability, therapeutic effects, current pharmaceutical/industrial use, and innovation potential. Antioxidants. 2022 Dec 26;12(1):48.
- Adelusi TI, Oyedele AQ, Boyenle ID, Ogunlana AT, Adeyemi RO, Ukachi CD, Idris MO, Olaoba OT, Adedotun IO, Kolawole OE, Xiaoxing Y. Molecular modeling in drug discovery. Informatics in Medicine Unlocked. 2022 Jan 1;29:100880.
- Bülow RD, Boor P. Extracellular matrix in kidney fibrosis: more than just a scaffold. Journal of Histochemistry & Cytochemistry. 2019 Sep;67(9):643-61.
- Wu H, Wei M, Li Y, Ma Q, Zhang H. Research progress on the regulation mechanism of key signal pathways affecting the prognosis of glioma. Frontiers in Molecular Neuroscience. 2022 Jul 22;15:910543.
- Wang J, Xiang H, Lu Y, Wu T, Ji G. New progress in drugs treatment of diabetic kidney disease. Biomedicine & Pharmacotherapy. 2021 Sep 1;141:111918.
- Klingberg F, Hinz B, White ES. The myofibroblast matrix: implications for tissue repair and fibrosis. The Journal of pathology. 2013 Jan;229(2):298-309.
- Sureshbabu A, Muhsin SA, Choi ME. TGF-β signaling in the kidney: profibrotic and protective effects. American Journal of Physiology-Renal Physiology. 2016 Apr 1;310(7):F596-606.
- Gu YY, Liu XS, Huang XR, Yu XQ, Lan HY. Diverse role of TGF-β in kidney disease. Frontiers in cell and developmental biology. 2020 Feb 28;8:123.
- Bochořáková H, Paulová H, Slanina J, Musil P, Táborská E. Main flavonoids in the root of Scutellaria baicalensis cultivated in Europe and their comparative antiradical properties. Phytotherapy Research. 2003 Jun;17(6):640-4.
- Ullah A, Munir S, Badshah SL, Khan N, Ghani L, Poulson BG, Emwas AH, Jaremko M. Important flavonoids and their role as a therapeutic agent. Molecules. 2020 Nov 11;25(22):5243.
Volume | 02 |
Issue | 01 |
Received | February 15, 2024 |
Accepted | March 19, 2024 |
Published | March 28, 2024 |